Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
First Trust Nasdaq Pharmaceuticals ETF
(NQ:
FTXH
)
27.21
-0.03 (-0.10%)
Official Closing Price
Updated: 1:15 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about First Trust Nasdaq Pharmaceuticals ETF
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
August 19, 2024
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Product Safety
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
June 27, 2024
The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,...
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Pharma ETFs have delivered mixed performances over the past month.
Via
Talk Markets
Topics
ETFs
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth.
Via
Talk Markets
Topics
ETFs
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Pharma ETFs have been in the green over the past month.
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.
Via
Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
September 25, 2021
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations.
Via
Talk Markets
Exposures
COVID-19
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.
Via
Talk Markets
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.